Effect of Antifibrotic Therapy on Survival in Patients With Idiopathic Pulmonary Fibrosis
Open Access
- 28 March 2023
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 45 (4) , 306-315
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group ReportAmerican Journal of Respiratory and Critical Care Medicine, 2016
- Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trialsRespiratory Medicine, 2016
- Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosisEuropean Respiratory Journal, 2015
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2014
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2014
- Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2011
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational StudiesMultivariate Behavioral Research, 2011
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- A sequential Cox approach for estimating the causal effect of treatment in the presence of time‐dependent confounding applied to data from the Swiss HIV Cohort StudyStatistics in Medicine, 2010
- Matching Methods for Causal Inference: A Review and a Look ForwardStatistical Science, 2010